zofran 16 milligram suppositories
novartis pharmaceuticals uk ltd - ondansetron - suppositories - 16 milligram - serotonin (5ht3) antagonists
zofran 4 milligram film coated tablet
novartis pharmaceuticals uk ltd - ondansetron hydrochloride - film coated tablet - 4 milligram - serotonin (5ht3) antagonists
zofran 8 milligram film coated tablet
novartis pharmaceuticals uk ltd - ondansetron hydrochloride - film coated tablet - 8 milligram - serotonin (5ht3) antagonists
zofran 4 mg/5 ml mg/5ml syrup
novartis pharmaceuticals uk ltd - ondansetron hydrochloride dihydrate - syrup - 4 mg/5 ml mg/5ml - serotonin (5ht3) antagonists
zofran ondansetron (as hydrochloride dihydrate) 8 mg/4 ml injection sterile syringe
aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium chloride; sodium citrate dihydrate - for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for the prevention and treatment of post-operative nausea and vomiting. indications as at 25 july 1994: . for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy; . for the prevention and treatment post-operative nausea and vomiting.
zofran ondansetron (as hydrochloride dihydrate) 4 mg/2 ml injection sterile syringe
aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium citrate dihydrate; citric acid monohydrate - for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. for the prevention and treatment of post-operative nausea and vomiting. indications as at 25 july 1994: . for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy; . for the prevention and treatment post-operative nausea and vomiting. indications as at 10th february 1997: the prevention and treatment of post-operative nausea and vomiting in paediatric patients aged 2-12 years.
zofran 8mg tablets
novartis pharmaceuticals uk ltd - ondansetron hydrochloride dihydrate - oral tablet - 8mg
zofran 4mg tablets
novartis pharmaceuticals uk ltd - ondansetron hydrochloride dihydrate - oral tablet - 4mg
zofran 4mg/5ml syrup
novartis pharmaceuticals uk ltd - ondansetron hydrochloride - oral solution - 800microgram/1ml
zofran 16mg suppositories
novartis pharmaceuticals uk ltd - ondansetron - suppository - 16mg